Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo
<iframe src="https://hindustansphere.com/embed/cluster/c5338cc99f2ff6da298f0a75873e93c7d96524ba" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Ebola vaccine trial begins in DR Congo"></iframe>
Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo
Ervebo, a vaccine approved for use against the more common Zaire strain of Ebola, will be put through a full-scale human trial in the DRC to see if it offers any cross-protection against Bundibugyo
